Abstract:Background Enantiomerically pure alcohols are important building blocks for production of chiral pharmaceuticals, flavors, agrochemicals and functional materials and appropriate whole-cell biocatalysts offer a highly enantioselective, minimally polluting route to these valuable compounds. At present, most of these biocatalysts follow Prelog’s rule, and thus the ( S )-alcohols are usually obtained when the smaller substituent of the ketone has the lower CIP priority. Only a few anti-Prelog ( R )-specific whole cell biocatalysts have been reported. In this paper, the biocatalytic anti-Prelog reduction of 2-octanone to ( R )-2-octanol was successfully conducted with high enantioselectivity using whole cells of Acetobacter pasteurianus GIM1.158. Results Compared with other microorganisms investigated, Acetobacter pasteurianus GIM1.158 was shown to be more effective for the reduction reaction, affording much higher yield, product enantiomeric excess ( e.e. ) and initial reaction rate. The optimal temperature, buffer pH, co-substrate and its concentration, substrate concentration, cell concentration and shaking rate were 35°C, 5.0, 500 mmol/L isopropanol, 40 mmol/L, 25 mg/mL and 120 r/min, respectively. Under the optimized conditions, the maximum yield and the product e.e. were 89.5% and >99.9%, respectively, in 70 minutes. Compared with the best available data in aqueous system (yield of 55%), the yield of ( R )-2-octanol was greatly increased. Additionally, the efficient whole-cell biocatalytic process was feasible on a 200-mL preparative scale and the chemical yield increased to 95.0% with the product e.e. being >99.9%. Moreover, Acetobacter pasteurianus GIM1.158 cells were proved to be capable of catalyzing the anti-Prelog bioreduction of other prochiral carbonyl compounds with high efficiency. Conclusions Via an effective increase in the maximum yield and the product e.e. with Acetobacter pasteurianus GIM1.158 cells, these results open the way to use of whole cells of this microorganism for challenging enantioselective reduction reactions on laboratory and commercial scales.

A Study and Application of Biocatalytic Synthesis of (S)-N-Boc-3-hydroxypiperidine

A Novel Asymmetric Synthesis of Cis-(3r, 4R)-N-(tert-butoxycarbonyl)-4-methyl-3-(methylamino) Piperidine

Development of a Practical Biocatalytic Process for ( S )- N -Boc-3-hydroxypiperidine Synthesis

Enantioselective synthesis of (S)-1-Boc-3-hydroxypiperidine using enzymes and whole cell biocatalysts

Biocatalytic Asymmetric Synthesis of L-Phosphinothricin Using a One-Pot Three Enzyme System and a Continuous Substrate Fed-Batch Strategy

Biocatalytic anti-Prelog reduction of prochiral ketones with whole cells of a newly isolated strain Empedobacter brevis ZJUY-1401

Biocatalytic Asymmetric Synthesis of Chiral Aryl Alcohols

Improved Enantioselectivity of E. Coli BioH in Kinetic Resolution of Methyl (S)-3-cyclohexene-1-carboxylate by Combinatorial Modulation of Steric and Aromatic Interactions

Asymmetric Bioreduction of 4-hydroxy-2-butanone by Carbonyl Reductases PFODH and CpSADH Delivers 1,3-butanediol Enantiomers with Excellent R - and S -enantioselectivity

Synthesis of enantiopure (S)-6-chlorochroman-4-ol using whole-cell Lactobacillus paracasei biotransformation

Convenient Preparation of Chiral Phase-Transfer Catalysts with Conformationally Fixed Biphenyl Core for Catalytic Asymmetric Synthesis of Α-Alkyl- and Α,α-Dialkyl-α-amino Acids: Application to the Short Asymmetric Synthesis of BIRT-377.

Biocatalytic Ketone Reduction: A Green and Efficient Access to Enantiopure Alcohols

An Engineered Imine Reductase for Highly Diastereo- and Enantioselective Synthesis of Β-Branched Amines with Contiguous Stereocenters

Efficient Biocatalytic Synthesis of Chiral Chemicals.

Using Water-Miscible Ionic Liquids to Improve the Biocatalytic Anti-Prelog Asymmetric Reduction of Prochiral Ketones with Whole Cells of Acetobacter Sp. CCTCC M209061

Biocatalytic Desymmetrization for the Atroposelective Synthesis of Axially Chiral Biaryls Using an Engineered Imine Reductase

Biocatalytic anti-Prelog reduction of prochiral ketones with whole cells of Acetobacter pasteurianus GIM1.158

(S)-1-Boc-3-hydroxypiperidine synthesis method

Improving the Enantioselectivity of CHMO Brevi1 for Asymmetric Synthesis of Podophyllotoxin Precursor

Synthesis of Enantioenriched 2-Alkyl Piperidine Derivatives Through Asymmetric Reduction of Pyridinium Salts.

Significantly Enhancing the Biocatalytic Synthesis of Chiral Alcohols by Semi-Rationally Engineering an Anti-Prelog Carbonyl Reductase from Acetobacter Sp. CCTCC M209061